Latest
industry research report on: Cancer Genetics Inc (CGIX) Market :
Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand,
Growth, Segmentation, Parameters, Forecasts
Cancer Genetics Inc (CGI)
is a pharmaceutical company that provides diagnostics products and
services in oncology areas. The company offers products such as CGH
Microarrays, Next-Generation Sequencing and DNA-FISH Probes. Its
oncology tests and laboratory services offer critical genomic
information to healthcare professionals, biopharma companies, and cancer
centers. CGIs clinical services include expand DX, test menu, complete
program, and summation report. The company offers a range of
pharmacogenomics testing services for clinical oncologists, cancer
centers, and research institutions, and for biotech and biopharma
customers engaged in clinical trials. It works in research collaboration
with cancer centers to develop and validate proprietary tests. CGI is
headquartered in Rutherford, New Jersey, the US.
This
report is a source for data, analysis, and actionable intelligence on
the companys portfolio of pipeline products. The report provides key
information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Download Sample copy of this Report at :http://www.marketresearchreports.biz/sample/sample/948180
Scope:
-
The report reviews detailed company profile with information on
business description, key company facts, major products and services,
key competitors, key employees, locations and subsidiaries and recent
developments
- The report analyzes all pipeline products in development for the company Cancer Genetics Inc
-
The report provides pipeline analysis on all pipeline products of the
company (by equipment type, by indication, by development stage, and by
trial status)
-
The report covers detailed information on each pipeline product with
information on pipeline territory, stage of development, device class,
regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
-
The report also covers ongoing clinical trials (wherever applicable)
with information on trial name, trial objective, sponsor, trial design ,
trial status and phase, estimated start and end date.
Reasons to Buy:
-
Develop business strategies by understanding the trends and
developments driving the medical devices pipeline and technology
landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
-
Identify emerging players with potentially strong product portfolio and
create effective counter-strategies to gain competitive advantage
-
Develop competition strategies by identifying the status and likely
launch of the competitors pipeline products through review of the
clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Cancer Genetics Inc Company Overview 6
Cancer Genetics Inc Company Snapshot 6
Cancer Genetics Inc Pipeline Products and Clinical Trials Overview 7
Cancer Genetics Inc Pipeline Analysis Overview 10
Key Facts 10
Cancer Genetics Inc - Major Products and Services 11
Cancer Genetics Inc Pipeline Products by Development Stage 12
Cancer Genetics Inc Pipeline Products Overview 14
Diagnostic Panel - Myelodysplastic Syndrome 14
Diagnostic Panel - Myelodysplastic Syndrome Product Overview 14
FHACT Test - Head and Neck Cancer 15
FHACT Test - Head and Neck Cancer Product Overview 15
FReCaD Renal Cancer Test 16
FReCaD Renal Cancer Test Product Overview 16
LeukA - Leukemia 17
LeukA - Leukemia Product Overview 17
MatBA Diagnostic Test - Marginal Zone Lymphoma 18
MatBA Diagnostic Test - Marginal Zone Lymphoma Product Overview 18
MatBA Diagnostic Test - Multiple Myeloma 19
MatBA Diagnostic Test - Multiple Myeloma Product Overview 19
Next-Gen DNA Sequencing Assay - Follicular Lymphoma 20
Next-Gen DNA Sequencing Assay - Follicular Lymphoma Product Overview 20
Next-Generation Sequencing Based Test - Lung Cancer 21
Next-Generation Sequencing Based Test - Lung Cancer Product Overview 21
UGenRA - Cervix 22
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time
and money for our clients. We are a one stop solution for all your
research needs, our main offerings are syndicated research reports,
custom research, subscription access and consulting services. We serve
all sizes and types of companies spanning across various industries.
Contact
Mr. Nachiket
State Tower
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-621-2074
No comments:
Post a Comment